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Abstract
Genetic alterations can cause cancer, including pancreatic cancer (PC) as well as cer-
tain neurodegenerative diseases. Our lab has recently identified genes that are modulated 
during pancreatic cancer liver metastasis, and some are known to have a role in neurobiol-
ogy or neurodegenerative diseases. Autophagy or self-eating portrays the lysosomal-
dependent degradation and recycling of protein aggregates and defective organisms 
in eukaryotic cells. Deregulation of autophagy as a cellular mechanism is common in 
neurodegenerative diseases as well as cancer and may represent a platform by which some 
genes can affect both disorders. This is exemplified for optineurin, which is an autophagy 
receptor that was found among genes with intensive modulation of expression in PC liver 
metastasis. Our results on this autophagy receptor draw the attention to the expression 
status of this and other autophagy genes in pancreatic cancer progression.
Keywords: pancreatic cancer, nervous system, neurodegenerative diseases, 
autophagy, optineurin
1. Introduction
Recent findings from microarray analyses of cancer cells have shown a growing list 
of genes with modulated expression, which are known to have importance in diseases 
other than cancer. This is in particular true for genes or gene families that have been 
identified to play a role in some neurodegenerative diseases or are a factor in cells of 
the nervous system, which may have a controlling role on the growth and development 
of cancer in general and of pancreatic cancer in particular. One cellular property, the 
alteration of which seems to be related to both types of diseases, is autophagy. In the 
lines below, we will discuss whether deregulation of autophagy could be a mechanism, 
which is in common between certain neurodegenerative diseases and pancreatic cancer, 
and thus may represent a link between two extremely different diseases.
2. Disrupted autophagy links cancer and neurodegenerative diseases
Autophagy is a Greek term that means self-eating and it portrays the lysosomal-
dependent way of degrading and recycling cytosolic components in eukaryotic 
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cells. Autophagy is categorized into three different types, that is, microautophagy, 
macroautophagy, and chaperone-mediated autophagy (Figure 1), which are differ-
ent in terms of their cargo and the mechanism of their occurrence [1, 2].
Micro-autophagy refers to the process where minute parts of the cytoplasm become 
sequestered and later on completely engulfed by lysosomal invaginations [3].
Chaperone-mediated autophagy is a selective pathway of autophagy, where 
proteins are targeted by the presence of a pentapeptide motif in the amino acid 
sequence of the substrate proteins, which is recognized by a chaperone protein. This 
complex is then delivered to the lysosomes for degradation in a receptor-dependent 
manner [2]. The motif should be accessible to the chaperone protein regardless of 
its position in the protein, but under normal conditions, it is concealed within the 
core when the protein is appropriately folded. Substrates for CMA are recognized 
by chaperones as heat shock cognate protein of 70 kD (hsp70) and cochaperones, 
which may be responsible for the unfolding of the protein before substrate-
chaperone interaction can take place, but without direct interactions in some 
cases. Cochaperones include proteins PINK  as hsp90, hsp40, and Bcl-2–associated 
athanogene 2 (Bag-1). Then, the substrates bind to the cytosolic tail of lysosome-
associated membrane protein type 2A (LAMP-2A) and through its multimerization 
are translocated toward the lysosomal lumen, and this is seen as a limiting step for 
the pathway [2, 4, 5].
Macroautophagy, referred to below as autophagy, is the most widely 
investigated type of autophagy and entails the formation of what is called an 
autophagosome, which is a double membrane structure that is used to deliver 
cargos later through fusion to lysosomes or endosomes [6]. It is formed through 
several chronological steps starting from nucleation, elongation, to closure of a 
phagophore or isolation membrane that leads to the autophagosome formation. 
Proteins responsible to drive the autophagy process were basically discovered 
through analyzing the yeast genome and are named autophagy-related (ATG) 
proteins [6, 7].
Once stimulated, the autophagic process starts with the assembly of the initia-
tion complex (ULK1 complex) and the nucleation complex (BECN1 complex) at the 
phagophore assembly site and this forms the basis for recruiting other ATG proteins 
and the elongation of the phagophore membrane [1]. ATG8/LC3 becomes bound to 
the inner and outer membrane of the phagophore following cleavage by the ATG4 
protease and following conjugation to phosphatidylethanolamine (PE). Before 
Figure 1. 
Schematic representation of the three different types of autophagy showing the underlying difference in the 
mechanisms, microautophagy by invaginations of the lysosomes, macroautophagy through the formation of 
autophagosomes, and CMA with the targeted protein recognized by chaperones and delivered to the lysosomes 
through the LAMP2 protein.
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closure, all ATGs dissociate and are recycled except for ATG8/LC3, which is located 
on the outer membrane. This protein is recycled after closure with the assistance of 
ATG4, while lysosomal enzymes in the autophagosome lumen degrade the ATG8/
LC3 attached to the inner membrane.
Autophagosomes later unite with late endosomes and lysosomes to proceed for 
degradation [1]. LAMP proteins again control the fusion step and protect against 
degradation of the lysosomal membrane [1, 8].
Autophagy can be either selective or nonselective. During the selective process, 
specific cargos as aggregated proteins, damaged mitochondria, excess peroxisomes, 
and invading pathogens undergo degradation after being recognized via autophagy 
receptors. These autophagy receptors have the ability to recognize degradation 
signals on cargo proteins and also bind LC3/GABARAP proteins on the forming 
autophagosome. Among the identified autophagy receptors are p62/SQSTM1 (p62/
Sequestosome 1), OPTN (optineurin), NBR1 (neighbor of BRCA1), and NDP52 
(nuclear dot protein 52 kDa). All of them possess an ubiquitin-binding domain and 
LC3-interacting regions (LIRs) [9, 10].
Autophagy is a highly conserved process in mammals and is strictly regulated. 
One of the major regulators is mTOR through its complex 1 (mTORC1) and its acti-
vation exerts an inhibitory effect on autophagy induction. A similar effect is shown 
with PI3 kinases class I, whereas PI3 kinase class III activity is required for autopha-
gosome formation. Starvation and amino acid depletion result in stimulation of 
the process. Other regulatory and autophagy inducers are based on an increase 
in cytosolic calcium, inhibition of inositol triphosphate, or starvation-induced 
autophagy [6, 11, 12]. Starvation also positively regulates autophagy by activation 
of AMPK that directly phosphorylates ULK1 or by inhibition of mTORC1 activity, 
or through inhibitory phosphorylation of nonautophagic BECN1 complexes [1]. 
Oxidative stress [13], DNA damage [14], and hypoxia [15] are all among the cellular 
mechanisms that can induce autophagy.
Autophagy has several cellular functions; it provides nutrients, eliminates 
damaged proteins and organelles, combats against invading microorganisms/
pathogens, and in general keeps the homeostasis and balance in cells [1]. Because of 
its important role and significant cellular implications, defects or deregulation of 
this process was detected in different human diseases [1]. Infections and pathogens 
modulate autophagy according to their requirements to secure their survival in 
host cells. Certain steps of autophagy are hindered in neurodegenerative disorders 
and proteinopathies are a feature of these disorders. Autophagy is cytoprotective 
in cardiovascular tissue under physiological conditions, but it is induced in many 
cardiovascular diseases and is also deregulated in cancer, diabetes, and immune 
disorders [1].
2.1. Role of autophagy in cancer
In cancer, autophagy can either inhibit or promote cancer development and 
progression, and this varies according to the genetic lesions, tumor type, and stage. 
Combating mutagenic reactive oxygen species (ROS) accumulation, DNA damage, 
genomic instability, and oncogenic proteins are part of the protective functions of 
autophagy against tumor induction, as they induce autophagy when initiated [16, 17].
With regard to its onco-stimulatory role, downregulation of some autophagy-
related genes, as Beclin-1 or ATG5, results in reduced growth of metastatic 
carcinoma cell lines, while that of ATG7 will promote apoptosis of colon cancer 
cells. Autophagy also permits tumors to resist stress and apoptotic signals and is 
connected in advanced cancer to poor prognosis and invasiveness. It increases 
ATP levels that support cell survival during hypoxia and starvation. Thus, 
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autophagy keeps healthy cells away from malignant transformation through 
maintaining the cellular homeostasis, but after tumor establishment, it may result 
in increased tumor progression and invasiveness [16, 17]. Autophagy supports 
tumor development through improving resistance of cells to endogenous apop-
totic signals as well as resistance to chemotherapy and maintains the cancer stem 
cell compartment [17].
Pancreatic tumors show an elevated level of basal autophagy, more than any 
other epithelial cancer. The role of autophagy in PDAC needs to be clarified; as 
some investigations and the effect of anticancer drugs that generate ROS and 
induce autophagy give rise to the idea that autophagy is protective against cancer 
and stimulates apoptotic cancer cell death following treatment [18]. On the other 
hand, a number of reports suggested the role of autophagy in PDAC develop-
ment. Autophagy was anticipated to be the cellular mechanism responsible for 
cancer development and progression from pancreatitis to overt carcinogenesis in 
the presence of K-ras mutations. Different observations supported a harmful role 
of autophagy, as being strongly induced in the inflammatory process. Inhibition 
of tumor development was observed after using the autophagy inhibitor chloro-
quine. Finally, LC3 is overexpressed in pancreatic cancer and downregulation of 
autophagy genes significantly reduces the growth and colony formation of PDAC 
cells in vitro [19, 20].
2.2. Role of autophagy in neurodegenerative diseases
Autophagic removal of proteins and damaged organelles is vital for the appro-
priate function of neurons, not only under pathological conditions, but also at 
baseline level under normal circumstances, as denoted by some studies [21].
Autophagosomes are very rarely detected in healthy neurons owing to the fact 
that the brain has a very low level of basal autophagy, or because the robust effi-
ciency of the autophagy processes prevents the autophagosomes from accumulation 
[21, 22].
Dysfunction in autophagy affects the neuronal function and results in the occur-
rence of neurodegenerative diseases [23].
Induction of autophagy was anticipated to be an early stress response in axonal 
dystrophy and to contribute to axon remodeling [24]. Autophagy was shown to 
play a role in controlling microtubule dynamics and axon regeneration. Autophagy 
induction encouraged neurite growth, lessened the inhibitory effects of myelin, and 
reduced the formation of retraction bulbs after axonal injury in cultured cortical 
neurons [25].
Neurodegeneration is associated with deterioration of cognitive capabilities as 
well as motor functions with progressive damage to the nerve structure and func-
tions. Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis, and Huntington’s 
diseases represent the most famous neurodegenerative diseases [26]. They share 
in common the accumulation of toxic misfolded protein aggregates, as extracel-
lular amyloid protein (Aβ) plaques and intracellular accumulation of tau protein in 
Alzheimer’s disease, α-synuclein and ubiquitin in Parkinson’s disease, and mutant 
Huntingtin protein in Huntington’s disease [26]. Defective mitochondria, generat-
ing excessive reactive oxygen species (ROS), represent another feature of neurode-
generative diseases, as ROS harm the cellular constituents including DNA, lipids, 
and proteins [26]. The misfolded proteins are responsible for neuronal damage 
and death, and hence autophagy becomes a crucial target for the management of 
neurodegenerative diseases [27].
Recent studies revealed that alterations in autophagy-related genes trigger 
neurodegenerative diseases [28].
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In Alzheimer’s disease, transmembrane amyloid precursor protein (APP) 
is processed by β- and γ-secretases, which thus produce Aβ peptide [28, 29]. 
Autophagosomes show γ-secretase activity and represent a possibly active compart-
ment for the production of Aβ and contribute to its deposition in affected neurons 
in Alzheimer’s disease [30]. Dysfunction of Presenilin-1, associated with familial 
Alzheimer’s disease, hinders proteolysis in autolysosomes and results in accumu-
lation of Aβ peptides in autophagosomes [28]. Beclin-1 deficiency impedes the 
autophagic clearance of APP as an autophagy substrate, and it increases the pathol-
ogy of Alzheimer’s disease [31].
Huntington’s disease is an inherited neurodegenerative disease and shows a 
range of declining motor, behavioral, and cognitive functions. Mutations in the 
huntingtin (HTT) gene are associated with cytosine-adenine-guanine (CAG) 
expansion, encoding a polyglutamine (polyQ ) at the N-terminus of the gene [32]. 
This mutation affects the interaction of huntingtin with other proteins leading to 
all the neuropathological changes observed in the disease [33]. Huntingtin protein 
was shown to function as a scaffold protein for selective macroautophagy through 
interaction with autophagy pathway components; it cooperates with the autophagy 
receptor p62 and enables its connection with the essential autophagosome element 
LC3 and with ubiquitinated substrates. Huntingtin also binds to ULK1, the initiator 
kinase for autophagy, and this interaction liberates ULK1 from the negative regula-
tion exerted by mTOR [34].
Parkinson’s disease (PD) is a common progressive neurological disorder charac-
terized by tremors, bradykinesia, rigidity, and loss of postural reflexes. The disease 
is caused by the loss of dopaminergic neurons in the substantia nigra [28, 35]. 
Different stages of Parkinson’s disease showed deregulation of autophagy with the 
aggregation of α-synuclein in ‘Lewy bodies.’ Disrupted mitophagy is a major mecha-
nism in the pathogenesis of the disease through mutations of PINK1 and PARKIN, 
which are essential for mitochondrial biogenesis and recycling [36]. Physiologically, 
PINK1 is a target of the ubiquitin-proteasome system after it has been processed by 
the mitochondrial protease presenilin-associated rhomboid-like (PARL). In depo-
larized mitochondria, this process is inhibited and PINK1 accumulates on the outer 
mitochondrial membrane, autophosphorylates, and recruits Parkin to damaged 
mitochondria. Parkin is an enzyme 3 (E3) ubiquitin ligase, and it was suggested 
that its ubiquitinated proteins recruit the autophagy receptor p62 to be integrated 
in an autophagosome for the autophagy degradation of damaged mitochondria 
(mitophagy) [28].
The two autophagy receptors previously linked to xenophagy, nuclear dot pro-
tein 52 kDa (NDP52) and optineurin (OPTN), were identified in a recent study to 
be the primary receptors for PINK1- and Parkin-mediated mitophagy. In this study, 
PINK1 recruits these two autophagy receptors, but not p62, to activate mitophagy 
directly, independent from Parkin. Upon their recruitment to mitochondria, NDP52 
and OPTN recruit other autophagy components as ULK1, DFCP1, and WIPI1, thus 
revealing a function for these autophagy receptors upstream of LC3. While PINK1 
begins mitophagy in the absence of Parkin, mitophagy is significantly boosted in 
the presence of Parkin [37].
Amyotrophic lateral sclerosis is a deadly progressive neurodegenerative disease 
characterized by the degeneration and deterioration of motor neurons. Beside 
the association of several genes in ALS, it has been reported that mutations in the 
Sigma-1 receptor (SigmaR1) are related to the autosomal recessive familial form of 
ALS [28, 38]. SigmaR1 controls calcium transport and its reduced expression can 
lead to the increased release of calcium from ER, the depolarization of mitochon-
drial membrane potential, and apoptosis. It reduces autophagic flux and autophagic 
degradation [28, 39]. Recent exome sequencing studies identified TANK-binding 
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kinase 1 (TBK1) as an important protein in both sporadic and familial ALS. TBK1 
phosphorylates OPTN [40], and it was reported that a mutation of OPTN is also 
associated with ALS [41]. Furthermore, neuron-specific Atg5 and Atg7 knockout 
mice are associated with motor defects [42]. Beclin-1, the major player in the 
autophagic initiation process, has been shown to promote ALS by interacting with 
superoxide dismutase 1 (SOD1) and its downregulation was associated with aggre-
gation of amyloid-β tau tangles, which are indicators of Alzheimer’s disease (AD).
3. Link between autophagy and the nicotinic cholinergic system
The role of neurology genes in the progression and metastasis of cancer in 
general has been emphasized recently. In many reviews, Hildegard M. Schuller 
established the theory that modulation of the autonomic nervous system is respon-
sible for driving cancer development, progression, and resistance to chemotherapy 
not only in non–small-cell lung cancer and pancreatic ductal adenocarcinoma but 
also in other cancers [43–48].
She anticipated the different modifiable risk factors of PDAC development, 
including smoking, chronic psychological stress, and habitual ingestion of alcohol, 
to act mostly via the sensitization (α7nAChR) and desensitization (α4nAChR) of 
nAChRs that drive the expression of proteins, which regulate the synthesis and 
release of catecholamines and GABA and result in the hyperactivity of Gs-mediated 
cAMP signaling [47]. α7nAChR activation is responsible for the production of stress 
neurotransmitters, which are known to promote cancer features, as well as of sero-
tonin, dopamine, and glutamate, while the desensitization of α4nAChR is the main 
reason for reduced GABA levels, which is known to be a protective neurotransmitter 
[45]. This is believed to disturb the normal equilibrium and homeostasis of the sig-
naling neurotransmitters in favor of cancer development, progression, and reduced 
responsiveness to treatment [44].
A link between the nicotinic cholinergic system and autophagy can be thought 
as follows: in one study, nicotine hindered the macrophage clearance of mycobacte-
rium tuberculosis via inhibition of autophagosome formation in infected T helper 
cells and macrophages [49]. In another study, nicotine enhanced the proteasome 
activity and the total protein ubiquitination as well as autophagy as was proven by 
the occurrence of autophagic vacuoles and increased MAP LC3-II at protein level. 
These mechanisms help in the downregulation of connexin 43 and limit the com-
munication in endothelial cells based on the involvement of nAChR α4β2 and α3β2, 
but not α7 [50]. Jeong et al. have shown that melatonin’s neuroprotective effects 
against prion-mediated neural damage are owing to the activation of autophagy as 
an outcome of α7nAchR regulation [51].
4.  Modulated expression of some neurologic genes in PDAC with special 
reference to autophagy
Our lab has identified a group of genes, which are modulated during pancreatic 
cancer liver metastasis [52]. The microarray data are derived from ASML rat PDAC 
cells that were reisolated from rat liver after they had been implanted intraportally 
and colonized the rat liver for various periods of time. These genes were arranged 
according to their fold change versus control cells (more than threefold modula-
tion of expression) at early, intermediate, advanced, and final stages of metastasis, 
and the resulting genes were investigated by the Ingenuity Pathway Analysis 
program [53]. Among these genes, a subgroup was identified to have a dual role in 
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neurobiology and cancer metastasis. Thus, from ca. 30,000 genes, as found in a 
microarray experiment, 14 genes were selected as most promising. They are shown 
in Table 1. Data describing these genes are retrieved from the NCBI database [54].
From this list, some genes attracted our attention, including the autophagy 
receptor OPTN as well as MAOA/MAOB and CAV1.
What attracted our interest in this group of genes was that they share certain 
roles in cancer and neurology, and some were reported to have some direct or 
indirect link to autophagy.
The overexpression of the well-known mitochondrial enzyme MAOA, linked 
with many psychiatric illnesses, was shown to be associated with prostate cancer. 
MAOA caused neuroendocrine differentiation of prostate cancer cells through 
Gene symbol Summary
Upregulated genes
Receptor (G protein–coupled) 
activity modifying protein 1
Ramp1 Expression is increased in the striatum after 
repeated L-DOPA administration in a rat model of 
Parkinson’s disease.
Activating transcription factor 3 Atf3 Expression is rapidly upregulated in response to 
nerve injury.
Aristaless-like homeobox 3 Alx3 Preferential methylation of this gene’s promoter is 
associated with advanced-stage neuroblastoma.
Sortilin-related VPS10 domain-
containing receptor 2
Sorcs2 These genes are strongly expressed in the central 
nervous system.
MAP/microtubule affinity-
regulating kinase 4
Mark4 Expression is a potential marker for cancer, and the 
protein may also play a role in Alzheimer’s disease.
Chloride intracellular channel 6 Clic6 Elevated expression is correlated with poor 
prognosis in human gliomas.
Downregulated genes
Caveolin 1, caveolae protein Cav1 The protein helps in coupling integrins to the 
Ras-ERK pathway and in promoting cell cycle 
progression.
Neuritin 1 Nrn1 The encoded protein promotes neurite outgrowth 
suggesting its role in promoting neuritogenesis.
Monoamine oxidase A/B MaoA/MaoB They have an important role in the metabolism of 
neuroactive and vasoactive amines in the central 
nervous system and peripheral tissues.
5-hydroxytryptamine 
(serotonin) receptor 6, G 
protein–coupled
Htr6 This receptor is thought to regulate cholinergic 
neuronal transmission in the brain.
Ly6/neurotoxin 1 Lynx1 It has the capacity to enhance nicotinic 
acetylcholine receptor function in the presence of 
acetylcholine.
Calcium channel, voltage-
dependent, beta 4 subunit
Cacnb4 Certain mutations in this gene have been associated 
with idiopathic generalized epilepsy (IGE) and 
juvenile myoclonic epilepsy (JME). Multiple 
transcript variants for different isoforms have been 
found.
Optineurin Optn Optineurin plays a role in normal-tension glaucoma 
and adult-onset primary open angle glaucoma.
Table 1. 
Genes with modulated expression.
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activation of autophagy, ROS production, and downregulation of repressor ele-
ment-1 silencing transcription factor (REST) [55].
However, at mRNA level, MAOA was not measurably expressed in our panel of 
human PDAC cell lines. Another aspect, which prevented further experiments, was 
that the irreversible MAOA-inhibiting drug clorgyline halted the proliferation of 
BXPC3 cells only at very high concentrations, which rendered further studies of this 
gene unpromising.
Deficiency of the caveolae protein CAV1 stimulates the basal and induc-
ible autophagy as a cell survival mechanism under starvation. This is a recently 
described function of CAV1 and lipid rafts in breast cancer development via 
modulation of lysosomal function and autophagy [56]. Another study reported that 
CAV1 regulates autophagy positively under oxidative stress and cerebral ischemic 
injury. CAV1 deficiency limited localization of Beclin-1 (BECN1) to the mitochon-
dria and eliminated LC3 foci formation in response to hydrogen peroxide in the 
brain of CAV1 knockout mice [57]. CAV1 is related to tumorigenesis and metastasis. 
CAV1 overexpression in PDAC is associated with poor clinical outcome, as well as 
chemo- and radioresistance [58]. Moreover, signs of premature neuronal aging and 
degeneration are evident in CAV1 knockout mice together with increased Aβ, P-tau, 
and astrogliosis [59].
The gene optineurin (OPTN), which is an autophagy receptor, was also among the 
genes listed in Table 1. Since OPTN has an important role in many neurodegenera-
tive diseases as well as a function as an autophagy receptor, thus linking autophagy in 
cancer and neurodegenerative diseases, a comprehensive overview of this gene is given 
as well as an outline of the expression of other autophagy genes in PDAC.
5. Optineurin
OPTN is linked to many neurodegenerative diseases including normal ten-
sion glaucoma, primary open-angle glaucoma [60], as well as amyotrophic lateral 
sclerosis [41].
The OPTN gene is located on chromosome 10p13 and translates into a protein of 
67-kDa. The mRNA consists of 16 exons; the first 3 are noncoding, while the coding 
exons give rise to a protein composed of 577 amino acids [61, 62]. OPTN was found 
to be head to head oriented with the gene coiled-coil domain containing 3 (CCDC3) 
with a distance of about 98-kb between their 5’UTRs [63]. OPTN has a half-life of 
around 8 h and its degradation engages the ubiquitin proteasomal system as its level 
increases following exposure to a proteasome inhibitor, but not to autophagic or 
lysosomal inhibitors [64].
OPTN encompasses several domains: an NF-κB-essential molecule-like domain, 
leucine zipper motif, coiled-coil motifs, an ubiquitin-binding domain (UBD), an LC3-
interacting region, and a carboxyl (C)-terminal C2H2 type of zinc finger [65, 66].
As a cytoplasmic protein [60], OPTN colocalizes together with myosin VI and 
Rab8 around the Golgi complex and in vesicles at the plasma membrane [67]. 
It shows a high level of expression in certain tissues such as retina, brain, heart, 
skeletal muscle, placenta, testis, and kidney [68].
It interacts with itself to form homo-oligomers [69] and also with other molecules 
such as Ras-related protein 8 (Rab8) [70], huntingtin [71], myosin VI [72], transferrin 
receptor [68], LC3/GABARAP [62], polo-like kinase 1 [73, 74], TBK1 [75], as well as 
metabotropic glutamate receptor, transcription factor IIIA, serine/threonine kinase 
receptor-interacting protein 1, CYLD lysine 63 deubiquitinase (cylindromatosis, 
CYLD), and HECT (homologous to the E6-AP carboxyl terminus) domain and ankyrin 
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repeat containing E3 ubiquitin protein ligase 1 (HACE1) [65]. The structure of OPTN 
and some interactions are shown in Figure 2.
OPTN plays different roles under physiological conditions including membrane traf-
ficking, maintenance of the Golgi apparatus, exocytosis, protein secretion, cell division 
control, regulation of NF-κB, and host defense against pathogens [61, 62, 65, 67].
Its antiviral preventive response was based on its ability to regulate the inter-
feron response in a cell cycle–dependent manner owing to its nuclear translocation 
together with deubiquitinating enzyme CYLD during the G2/M phase of the cell 
cycle, which abolishes the inhibitory effect it exerts on TBK1. As a result, the TBK1 
activity is increased with enhanced interferon production [76].
The overexpression of OPTN was demonstrated to be protective against H2O2-
mediated cell death, a function, which is compromised by a mutated form of OPTN 
(E50K), resulting in cells that are less fit to survive under stress conditions [70].
Beside all the above stated roles, OPTN is considered as a disease-linked gene. 
Mutations of OPTN or its altered expression are associated with multiple diseases 
including normal tension glaucoma and primary open-angle glaucoma [60] as well 
as plenty of neurodegenerative diseases including amyotrophic lateral sclerosis 
[41], ubiquitin-positive intraneuronal inclusions in ALS with dementia, basophilic 
inclusions in the basophilic type of ALS, neurofibrillary tangles and dystrophic 
neurites in Alzheimer’s disease, Lewy bodies and Lewy neurites in Parkinson’s 
disease, ballooned neurons in Creutzfeldt-Jakob disease, glial cytoplasmic inclu-
sions in multiple system atrophy, and Pick bodies in Pick’s disease with unknown 
significance [77]. Reduced OPTN expression in humans might increase the risk of 
developing Crohn’s disease [78] and dispose to the occurrence of Paget’s disease by 
enhancing osteoclast differentiation, as OPTN is a recently identified regulator of 
bone resorption [79].
The OPTN protein was identified as a selective autophagy receptor such as the 
multidomain scaffold/adaptor protein p62/sequestosome-1 (p62/SQSTM-1) and 
nuclear domain 10 protein 52 (NDP52) in terms of binding to polyubiquitinated 
cargoes and brings them to autophagosomes via its LC3-interacting region [65, 
80–82]. In this context, it can help cells to get rid of pathogens as salmonella [80], 
defective mitochondria [82], and misfolded protein aggregates [83] or can have a 
role in tumor suppression [81].
The role of OPTN in autophagy can also be independent from ubiquitination 
[65], where it can distinguish several protein aggregates through its C-terminal 
coiled-coil domain [84].
Figure 2. 
Graphic illustration of OPTN structural domains and the localization of these domains relative to its amino 
acid sequence as well as some of its interacting proteins.
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The role of OPTN in autophagy extends beyond being an autophagy receptor, as 
OPTN also plays a role as an autophagy inducer. Overexpression of OPTN in its wild 
type or mutated E50K forms, or its upregulation by cytokine treatment, was linked 
to elevated LC3-II levels in retinal ganglion cells, while the level of the proteasome 
activity marker PSMB5 (proteasome regulatory β 5) was reduced denoting induc-
tion of autophagy [64]. In vivo results confirmed the induction of autophagy and 
the reduction of ubiquitin proteasome pathway upon the injection of wild type and 
E50K OPTN transfected vectors in rat eyes [85].
Mutation or altered expression of OPTN may result in many diseases as 
glaucoma, ALS, other neurodegenerative diseases [65], or even cancer [81] 
owing to the implication of mitochondrial dysfunction and protein aggregation 
[65]. Mutations in both autophagy receptors p62 and OPTN in Paget’s disease of 
the bone may attribute to an autophagy-related mechanism of developing this 
disease [65].
An overview of the RNA-seq data generated by the Cancer Genome Atlas (TCGA) 
revealed high expression of the OPTN gene across several cancer types (reported as 
median number fragments per kilo-base of exon per million reads (FPKM)) and was 
based on mRNA expression in cancer tissues (see Figure 3). In this regard and with 
data retrieved from the Protein Atlas website [86, 87], pancreatic cancer represents 
the tumor with the second highest OPTN expression and is topped only by renal 
cancer.
Prompted by this result, we analyzed the expression of autophagy genes and 
autophagy receptors in PDAC in a TCGA cohort with a sample size of 179. Most of 
the autophagy genes were above average genomic expression, represented by >7.5 
log2 rsem (RNA-seq by expectation maximization) except for ATG10, which was 
below average. OPTN was second highest expressed of all autophagy genes, pre-
ceded only by SQSTM1 (Figure 4).
Based on these findings, we reasoned that OPTN might be involved in important 
mechanisms associated with cancer as well as with neurodegenerative diseases that 
require further analysis.
Figure 3. 
Overview of the RNA-seq data in TCGA of 17 cancer cohorts showing the highest OPTN expression in renal 
cell carcinoma followed by PDAC (expressed in terms of median FPKM) [86–88].
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6. Conclusions
In summary, autophagy represents a link between the nervous system and 
cancer in general as well as pancreatic cancer in particular. The modulated expres-
sion of autophagy-related genes in cancer and neurodegenerative diseases highlights 
the importance of this mechanism and suggests further studies on their regulation 
and effective targeting. Autophagy is a new background for certain genes in cancer 
as well as in neurology, and understanding this process may well serve as a plat-
form for understanding the pathogenesis of these diseases in different organs. In 
addition, there seems to be a special role for OPTN in different neurodegenerative 
diseases as well as cancer and this protein could well be a target in cancer treatment. 
The link between nicotinic acetylcholine receptors and autophagy still requires 
further studies to be properly delineated.
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